Tyler Lecture with David Elkins
From Kimberly Ragan on October 28th, 2020
Chaplin Tyler Lecture featuring David Elkins, Executive Vice President and Chief Financial Officer, Bristol Myers Squibb Company.
Q&A will be moderated by Fei Xie, professor of finance and the Iannaccone Faculty Fellow, Lerner College.
David is the Executive Vice President and Chief Financial Officer of Bristol Myers Squibb Company (BMS). In addition, David has responsibility for Global Business Operations, which includes Strategic Sourcing & Procurement, Business Insights & Analytics, Investor Relations, and the Integration Management Office.
David joined BMS as a result of the acquisition of Celgene where he was Executive Vice President & CFO. Prior to Celgene, David served as Chief Financial Officer of Johnson & Johnson’s (J&J) Consumer Products, Medical Devices and Corporate Functions, with $40 billion in revenue. Prior to J&J, his experiences include Executive Vice President & Chief Financial Officer of Becton, Dickinson & Company, a leading global medical device company. From 1995 to 2008, David held roles of increasing responsibility at AstraZeneca working in the US, Asia, Europe and finished his career there as VP & CFO of North America. He was also a member of the management board of Medimmune Inc. after AstraZeneca’s acquisition of the company. David began his career in finance at The Boeing Company.
David earned his B.S. degree in Economics from the Lerner School of Business at the University of Delaware, an M.B.A. from Lebow School of Business at Drexel University and a M.S. degree in Organizational Dynamics from the University of Pennsylvania and completed the Wharton Executive Development Program. David has earned his Certified Management Accountant (CMA) and Certified Financial Manager (CFM) designations.
David has served on the Board of Directors for Corporation Services Company (CSC). He is supporter of the University of Delaware where he has served on the Audit Committee of the Board of Trustees, and currently serves on the Lerner Business School Dean’s Advisory Board and the UD Biopharmaceutical Innovation Board. He has also served on the Board of the United Way of Delaware.